Token导航 LogoToken导航TokenDH.com
研究检索需要联网clawhub未标认证来源可访问clear审计通过

adaptive-trial-simulator自适应试验模拟器

Agent Skill

adaptive-trial-simulator 用于记录任务执行中的错误、用户纠正、经验和能力缺口,适合在 OpenClaw 中希望让 Agent 持续沉淀问题、修正和最佳实践时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

总安装

6,060

周安装

250

GitHub Stars

公开资料未说明

下载量

1,980
OpenClaw

安装说明

本站只整理中文说明和来源信息,不托管安装包,也不代用户安装。

GitHub

来源数

2

许可证

MIT-0

最后核验

2026-05-01

来源状态

来源可访问

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:adaptive-trial-simulator(自适应试验模拟器)
来源仓库:https://github.com/aipoch-ai/adaptive-trial-simulator
安装命令:
openclaw skills install adaptive-trial-simulator
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 OpenClaw 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

ClawHubOpenClaw
openclaw skills install adaptive-trial-simulator

简介

设计和模拟适应性临床试验,评估 I 型错误控制与统计功效。

  • 支持中期分析、样本量重估与提前停止规则。
  • 适用于生物医药研发与临床研究规划。
  • 参数设置需符合监管指南要求。adaptive-trial-simulator 属于研究检索类 Skill,可作为该场景下的辅助能力补充。
  • 结果解释应由专业人员复核确认。

SKILL.md

name
adaptive-trial-simulator
description
Design and simulate adaptive clinical trials with interim analyses,
version
1.0.0
category
Clinical
tags
["clinical-trials", "adaptive-design", "statistics", "simulation", "biostatistics"]
author
AIPOCH
license
MIT
status
Draft
risk_level
Medium
skill_type
Tool/Script
owner
AIPOCH
reviewer
last_updated
2026-02-15

Adaptive Trial Simulator

Statistical simulation platform for designing and validating adaptive clinical trial designs in silico. Enables optimization of interim analysis strategies, sample size adaptation, and early stopping rules while maintaining Type I error control.

Features

  • Design Simulation: Monte Carlo validation of adaptive designs
  • Sample Size Re-estimation: Adapt sample size based on interim data
  • Early Stopping Rules: Futility and efficacy boundary optimization
  • Type I Error Control: Validate alpha spending strategies
  • Multi-Arm Designs: Drop-the-loser and seamless Phase II/III
  • Power Optimization: Identify designs with maximum power efficiency

Usage

Basic Usage

# Run standard group sequential design
python scripts/main.py

# Adaptive design with sample size re-estimation
python scripts/main.py --design adaptive_reestimate

# Optimize design parameters
python scripts/main.py --optimize

Parameters

ParameterTypeDefaultRequiredDescription
--designstrgroup_sequentialNoTrial design type
--n-simulationsint10000NoNumber of Monte Carlo simulations
--sample-sizeint200NoInitial sample size per arm
--effect-sizefloat0.3NoEffect size (Cohen's d)
--alphafloat0.05NoType I error rate
--powerfloat0.80NoTarget statistical power
--interim-looksint1NoNumber of interim analyses
--spending-functionstrobrien_flemingNoAlpha spending function
--reestimate-methodstrpromising_zoneNoSample size re-estimation method
--outputstrresults.jsonNoOutput file path
--visualizeflagFalseNoGenerate visualization charts
--optimizeflagFalseNoSearch for optimal design parameters

Advanced Usage

# Full adaptive design with visualization
python scripts/main.py \
  --design adaptive_reestimate \
  --n-simulations 50000 \
  --sample-size 250 \
  --effect-size 0.35 \
  --interim-looks 2 \
  --spending-function obrien_fleming \
  --visualize \
  --output adaptive_results.json

Design Types

Design TypeDescriptionUse Case
Group SequentialFixed interim looks with stopping boundariesStandard adaptive trials
Adaptive Re-estimateSample size adjustment based on interim dataUncertain effect size
Drop the LoserMulti-arm trials dropping inferior armsPhase II dose selection

Spending Functions

FunctionCharacteristicsEarly Boundary
O'Brien-FlemingConservative earlyHigh Z-scores early
PocockAggressive earlyLower Z-scores throughout
Power FamilyModerate (ρ=3)Balanced approach

Output Example

{
  "design_config": {
    "design_type": "adaptive_reestimate",
    "sample_size_per_arm": 200,
    "effect_size": 0.3,
    "alpha": 0.05,
    "target_power": 0.8
  },
  "simulation_results": {
    "power": 0.8234,
    "type_i_error": 0.0481,
    "expected_sample_size": 385.2,
    "early_stop_rate": {
      "efficacy": 0.1523,
      "futility": 0.0841
    }
  }
}

Technical Difficulty: HIGH

⚠️ AI自主验收状态: 需人工检查

This skill requires:

  • Python 3.8+ environment
  • NumPy, SciPy, and Matplotlib packages
  • Understanding of clinical trial statistics

Dependencies

pip install -r requirements.txt

Requirements

numpy>=1.20.0
scipy>=1.7.0
matplotlib>=3.4.0

Risk Assessment

Risk IndicatorAssessmentLevel
Code ExecutionPython scripts with mathematical calculationsMedium
Network AccessNo network accessLow
File System AccessWrites simulation resultsLow
Instruction TamperingStatistical parameters could affect resultsMedium
Data ExposureNo sensitive data exposureLow

Security Checklist

  • [x] No hardcoded credentials or API keys
  • [x] No unauthorized file system access
  • [x] Output does not expose sensitive information
  • [x] Input parameters validated
  • [x] Error messages sanitized
  • [x] Dependencies audited

Prerequisites

pip install -r requirements.txt
python scripts/main.py --help

Evaluation Criteria

Success Metrics

  • [ ] Simulations run without errors
  • [ ] Type I error controlled at nominal level
  • [ ] Power estimates are accurate
  • [ ] Visualizations generated correctly

Test Cases

  1. Basic Simulation: Default parameters → Valid results
  2. Different Designs: All design types → Appropriate behavior
  3. Optimization Mode: --optimize flag → Finds optimal parameters
  4. Visualization: --visualize flag → Charts generated

Lifecycle Status

  • Current Stage: Draft
  • Next Review Date: 2026-03-15
  • Known Issues: Type checking warnings with numpy arrays
  • Planned Improvements:

- Bayesian adaptive designs - Multi-arm multi-stage (MAMS) support - Enhanced visualization options

References

Available in references/:

  • Adaptive design statistical theory
  • Regulatory guidance documents
  • Alpha spending function literature
  • Sample size re-estimation methods

Limitations

  • Statistical Complexity: Requires biostatistics expertise
  • Simulation Time: Large simulations may take hours
  • Simplified Models: Does not capture all real-world complexities
  • Regulatory Consultation: Results should be validated with regulators

⚠️ DISCLAIMER: This tool provides simulation results for research and planning purposes only. All clinical trial designs should be reviewed by qualified biostatisticians and regulatory experts before implementation.

适合场景

01

OpenClaw 用户查找和安装 Skill 时

02

用户想查找某类 Agent Skill 时

03

需要根据任务场景推荐可安装能力包时

04

需要对比不同来源的安装命令和来源信息时

能力概览

能力 1

按任务关键词查找相关 Skills

能力 2

展示可复制的安装命令

能力 3

保留来源站点、仓库和原始说明,方便继续核验

能力 4

补充不同宿主或平台的使用分布数据

能力 5

展示第三方安全扫描或审计结果

安装后应在对应宿主中按原始 README 的触发条件使用;具体调用方式请以来源页面和 README 为准。

平台分布

OpenClaw

77.3%
按下载量换算1,531

安全审计

VirusTotal

通过

ClawScan

通过

Static analysis

通过

权限和风险

需要联网

该 Skill 可能需要联网访问来源站点、仓库或外部 API;具体网络访问范围需要结合源码和 README 复核。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。当前只有一个来源,正式发布前建议补源仓库或其他目录站核验。

来源信息

继续浏览同类 Skills